CR 241220 175.00P (CR241220P175000) Stock Options, News & Quotes

US OptionsDetailed Quotes

CR241220P175000

Watchlist

2.04
-3.96-66.00%

15min DelayClose Nov 25 16:00 ET

2.07High1.65Low

Intraday

5D
Daily

News

Double-Crane Pharmaceutical Gets Approval for China Clinical Trial of Weight Loss Drug
MT NewswiresNov 24 22:42 ET
Mobile Crane Market to USD 30.46 Billion by 2032 Owing to Surge in Construction and Infrastructure Development | Research Report by SNS Insider
Yahoo FinanceNov 22 07:19 ET
Crane Company (CR) Was Downgraded to a Hold Rating at Stifel Nicolaus
TipRanksNov 21 21:05 ET · Ratings
Yongmao Tower Crane Accident Case Adjourned to June 2025
MT NewswiresNov 20 18:57 ET
Those Who Invested in China Resources Double-Crane PharmaceuticalLtd (SHSE:600062) Three Years Ago Are up 104%
Simply Wall StNov 20 17:57 ET
Crane NXT Management to Meet With DA Davidson
TipRanksNov 20 09:56 ET

Comments

Insiders selling shares below current price and lack of purchases over the past year raises caution. Despite ownership, their selling activity suggests a lack of urgency to buy. However, company's earnings growth is positive.

Possible Bearish Signals With Crane Insiders Disposing Stock

Moomoo AI

Mar 13 08:04

Insiders selling shares below current price could indicate they believe shares are fully valued. Modest insider ownership suggests some alignment with other shareholders.

This Crane NXT Insider Reduced Their Stake By 10%

Moomoo AI

Feb 29 08:26

The growth in profits and high level of insider ownership in Crane makes it an appealing stock to keep an eye on. The alignment of goals between shareholders and management is seen as a positive sign.

Crane (NYSE:CR) Ticks All The Boxes When It Comes To Earnings Growth